Literature DB >> 21160280

Role of HIV-1 nucleocapsid protein in HIV-1 reverse transcription.

Judith G Levin1, Mithun Mitra, Anjali Mascarenhas, Karin Musier-Forsyth.   

Abstract

The HIV-1 nucleocapsid protein (NC) is a nucleic acid chaperone, which remodels nucleic acid structures so that the most thermodynamically stable conformations are formed. This activity is essential for virus replication and has a critical role in mediating highly specific and efficient reverse transcription. NC's function in this process depends upon three properties: (1) ability to aggregate nucleic acids; (2) moderate duplex destabilization activity; and (3) rapid on-off binding kinetics. Here, we present a detailed molecular analysis of the individual events that occur during viral DNA synthesis and show how NC's properties are important for almost every step in the pathway. Finally, we also review biological aspects of reverse transcription during infection and the interplay between NC, reverse transcriptase, and human APOBEC3G, an HIV-1 restriction factor that inhibits reverse transcription and virus replication in the absence of the HIV-1 Vif protein.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21160280      PMCID: PMC3073334          DOI: 10.4161/rna.7.6.14115

Source DB:  PubMed          Journal:  RNA Biol        ISSN: 1547-6286            Impact factor:   4.652


  253 in total

1.  Characterization of intracellular reverse transcription complexes of human immunodeficiency virus type 1.

Authors:  A Fassati; S P Goff
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

Review 2.  Mechanistic features of recombination in HIV.

Authors:  Román Galetto; Matteo Negroni
Journal:  AIDS Rev       Date:  2005 Apr-Jun       Impact factor: 2.500

Review 3.  Primer tRNAs for reverse transcription.

Authors:  J Mak; L Kleiman
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

4.  C-terminal domain modulates the nucleic acid chaperone activity of human T-cell leukemia virus type 1 nucleocapsid protein via an electrostatic mechanism.

Authors:  Dominic F Qualley; Kristen M Stewart-Maynard; Fei Wang; Mithun Mitra; Robert J Gorelick; Ioulia Rouzina; Mark C Williams; Karin Musier-Forsyth
Journal:  J Biol Chem       Date:  2009-11-03       Impact factor: 5.157

5.  In vitro characterization of the interaction between HIV-1 Gag and human lysyl-tRNA synthetase.

Authors:  Brandie J Kovaleski; Robert Kennedy; Minh K Hong; Siddhartha A Datta; Lawrence Kleiman; Alan Rein; Karin Musier-Forsyth
Journal:  J Biol Chem       Date:  2006-05-15       Impact factor: 5.157

6.  Structural basis for the specificity of the initiation of HIV-1 reverse transcription.

Authors:  C Isel; E Westhof; C Massire; S F Le Grice; B Ehresmann; C Ehresmann; R Marquet
Journal:  EMBO J       Date:  1999-02-15       Impact factor: 11.598

7.  Crystal structure of human immunodeficiency virus type 1 reverse transcriptase complexed with double-stranded DNA at 3.0 A resolution shows bent DNA.

Authors:  A Jacobo-Molina; J Ding; R G Nanni; A D Clark; X Lu; C Tantillo; R L Williams; G Kamer; A L Ferris; P Clark
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

8.  In vitro assembly properties of human immunodeficiency virus type 1 Gag protein lacking the p6 domain.

Authors:  S Campbell; A Rein
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

9.  Evidence for direct involvement of the capsid protein in HIV infection of nondividing cells.

Authors:  Masahiro Yamashita; Omar Perez; Thomas J Hope; Michael Emerman
Journal:  PLoS Pathog       Date:  2007-10-26       Impact factor: 6.823

Review 10.  HIV-1 Vif, APOBEC, and intrinsic immunity.

Authors:  Ritu Goila-Gaur; Klaus Strebel
Journal:  Retrovirology       Date:  2008-06-24       Impact factor: 4.602

View more
  99 in total

1.  The cellular antiviral protein APOBEC3G interacts with HIV-1 reverse transcriptase and inhibits its function during viral replication.

Authors:  Xiaoxia Wang; Zhujun Ao; Liyu Chen; Gary Kobinger; Jinyu Peng; Xiaojian Yao
Journal:  J Virol       Date:  2012-02-01       Impact factor: 5.103

2.  Selection of fully processed HIV-1 nucleocapsid protein is required for optimal nucleic acid chaperone activity in reverse transcription.

Authors:  Tiyun Wu; Robert J Gorelick; Judith G Levin
Journal:  Virus Res       Date:  2014-06-20       Impact factor: 3.303

Review 3.  Diverse interactions of retroviral Gag proteins with RNAs.

Authors:  Alan Rein; Siddhartha A K Datta; Christopher P Jones; Karin Musier-Forsyth
Journal:  Trends Biochem Sci       Date:  2011-05-06       Impact factor: 13.807

4.  Retroviral DNA Transposition: Themes and Variations.

Authors:  Anna Marie Skalka
Journal:  Microbiol Spectr       Date:  2014-12

5.  Allosteric HIV-1 Integrase Inhibitors Lead to Premature Degradation of the Viral RNA Genome and Integrase in Target Cells.

Authors:  Michaela K Madison; Dana Q Lawson; Jennifer Elliott; Ayşe Naz Ozantürk; Pratibha C Koneru; Dana Townsend; Manel Errando; Mamuka Kvaratskhelia; Sebla B Kutluay
Journal:  J Virol       Date:  2017-08-10       Impact factor: 5.103

6.  HIV-1 Pr55Gag binds genomic and spliced RNAs with different affinity and stoichiometry.

Authors:  Serena Bernacchi; Ekram W Abd El-Wahab; Noé Dubois; Marcel Hijnen; Redmond P Smyth; Johnson Mak; Roland Marquet; Jean-Christophe Paillart
Journal:  RNA Biol       Date:  2016-11-14       Impact factor: 4.652

Review 7.  Role of host tRNAs and aminoacyl-tRNA synthetases in retroviral replication.

Authors:  Danni Jin; Karin Musier-Forsyth
Journal:  J Biol Chem       Date:  2019-01-30       Impact factor: 5.157

8.  HIV restriction factor APOBEC3G binds in multiple steps and conformations to search and deaminate single-stranded DNA.

Authors:  Michael Morse; M Nabuan Naufer; Yuqing Feng; Linda Chelico; Ioulia Rouzina; Mark C Williams
Journal:  Elife       Date:  2019-12-18       Impact factor: 8.140

9.  Distinct nucleic acid interaction properties of HIV-1 nucleocapsid protein precursor NCp15 explain reduced viral infectivity.

Authors:  Wei Wang; Nada Naiyer; Mithun Mitra; Jialin Li; Mark C Williams; Ioulia Rouzina; Robert J Gorelick; Zhengrong Wu; Karin Musier-Forsyth
Journal:  Nucleic Acids Res       Date:  2014-05-09       Impact factor: 16.971

10.  Nucleocapsid Protein Precursors NCp9 and NCp15 Suppress ATP-Mediated Rescue of AZT-Terminated Primers by HIV-1 Reverse Transcriptase.

Authors:  Moisés A Árquez; Samara Martín-Alonso; Robert J Gorelick; Walter A Scott; Antonio J Acosta-Hoyos; Luis Menéndez-Arias
Journal:  Antimicrob Agents Chemother       Date:  2020-09-21       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.